Deutsche Märkte geschlossen

Mirion Technologies, Inc. (MIR)

NYSE - NYSE Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
11,37-0,02 (-0,18%)
Börsenschluss: 04:00PM EDT
11,60 +0,23 (+2,02%)
Nachbörse: 07:52PM EDT

Mirion Technologies, Inc.

1218 Menlo Drive
Atlanta, GA 30318
United States
770 432 2744
https://www.mirion.com

Sektor(en)Industrials
BrancheSpecialty Industrial Machinery
Vollzeitmitarbeiter3.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Thomas D. LoganFounder, Medical Group President, CEO & Director1,17MN/A1961
Mr. Brian SchopferChief Financial Officer634,91kN/A1985
Mr. Loic EloyGroup President of Technologies466,5kN/A1977
Mr. Christopher Moore CPAChief Accounting Officer & Principal Accounting OfficerN/AN/A1972
Mr. James CocksChief Technology OfficerN/AN/AN/A
Mr. Alex GaddySVP of Strategy, IR & TreasurerN/AN/AN/A
Ms. Emmanuelle LeeExecutive VP, General Counsel, Secretary & Chief Legal OfficerN/AN/AN/A
Erin SchesnyChief Marketing OfficerN/AN/AN/A
Alison UlrichChief Human Resources OfficerN/AN/AN/A
Mr. Bertrand DubanPresident of Nuclear MedicineN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Corporate Governance

Mirion Technologies, Inc.s ISS Governance QualityScore, Stand 1. März 2024, lautet 5. Die grundlegenden Scores sind Audit: 8, Vorstand: 5, Shareholderrechte: 6, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.